Coronavirus

Three recent papers showed how the new Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) compares in...

Study: Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains. Image Credit: nnattalli/Shutterstock

Monoclonal antibodies found to prevent lung inflammation in SARS-CoV-2-Omicron-infected mice

In a recent study posted to the bioRxiv* pre-print server, researchers investigated how monoclonal antibodies (MAbs), S309 and AZD7442, reduced...

Study: SARS-CoV-2 Omicron spike H655Y mutation is responsible for enhancement of the endosomal entry pathway and reduction of cell surface entry pathways. Image Credit: MedMoMedia/Shutterstock

Study finds that Omicron variant preferentially uses the endosome pathway through mutation in the spike protein

A recent study posted to the bioRxiv* preprint server assessed the role of the severe acute respiratory syndrome coronavirus 2...

Study: Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials. Image Credit: luchschenF/Shutterstock

Safety profile of colchicine in COVID-19 patients

In a recent systematic review and meta-analysis published in PLOS ONE, researchers evaluated the use of colchicine in coronavirus disease...

Study: Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022. Image Credit: spaxiax/Shutterstock

SARS-CoV-2 mRNA vaccines may prevent COVID-19-associated mechanical ventilation and death

In a recent study published in the Morbidity and Mortality Weekly Report, a team of researchers from the United States...

Study: Identification of a Novel SARS-CoV-2 Delta-Omicron Recombinant Virus in the United States. Image Credit: Ivan Marc/Shutterstock

New SARS-CoV-2 Omicron-Delta recombinant virus identified in the US

In a recent study posted to the bioRxiv* preprint server, researchers reported a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...

Study Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. Image Credit: Gil Cohen Magen / Shutterstock

COVID-19 protection increases after fourth vaccine dose but declines quickly

The emergence and rapid spread of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), caused the ongoing coronavirus...

Study: Discovery of a new generation of angiotensin receptor blocking drugs: receptor mechanisms and in silico binding to enzymes relevant to covid-19. Image Credit: Kateryna Kon/Shutterstock

Study identifies a novel class of angiotensin receptor blockers that interfere with SARS-CoV-2 spike – ACE2 interaction

Scientists have discovered a new generation of angiotensin receptor blockers that may be used to treat coronavirus disease 2019 (COVID-19)....

Recombinant SARS-CoV-2 Delta-Omicron variant identified in the United States

In a recent study published on the preprint server bioRxiv*, researchers find that there is likely recombination of genome sequences...

Study: The preference signature of the SARS-CoV-2 Nucleocapsid NTD for its 5’-genomic RNA elements. Image Credit: Orpheus FX/Shutterstock

Study explores favorable signatures for specific RNA motif recognition by SARS-CoV-2 nucleocapsid